An antagonist of α- and β-adrenoreceptors
Related Products
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Labetalol (hydrochloride)

Item No. 20249

Technical Information
Formal Name
2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]-benzamide, monohydrochloride
CAS Number
32780-64-6
Synonyms
  • AH 5158A
  • Normodyne
  • NSC 290312
  • SCH 15719W
  • Trandate
Molecular Formula
C19H24N2O3 • HCl
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 30 mg/mlDMSO: 15 mg/mlEthanol: 0.3 mg/ml
λmax
208, 303 nm
SMILES
OC1=CC=C(C(CNC(C)CCC2=CC=CC=C2)O)C=C1C(N)=O.Cl
InChi Code
InChI=1S/C19H24N2O3.ClH/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24;/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24);1H
InChi Key
WQVZLXWQESQGIF-UHFFFAOYSA-N
Shipping & Storage Information
Storage
Room temperature
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Labetalol is a competitive antagonist of both α- and β-adrenoreceptors that is effective at nanomolar concentrations.1,2 It is reported to control hypertension.3,4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Brittain, R.T., and Levy, G.P. A review of the animal pharmacology of labetalol, a combined α- and β-adrenoceptor-blocking drug. Br. J. Clin. Pharmacol. 3(4 suppl 3), 681-684 (1976).

    2. Richards, D.A. Pharmacological effects of labetalol in man. Br. J. Clin. Pharmacol. 3(4 suppl 3), 721-723 (1976).

    3. Owens, W.B. Blood pressure control in acute cerebrovascular disease. J. Clin. Hypertens. (Greenwich) 13(3), 205-211 (2011).

    4. Kernaghan, D., Duncan, A.C., and McKay, G.A. Hypertension in pregnancy: A review of therapeutic options. Obstet. Med. 5(2), 44-49 (2012).